12
IMCAS EDUCATIONAL GRANT PROGRAM V6 GRANT PROGRAM 15/11/2016
IMCAS EDUCATIONAL GRANT PROGRAM
V6 GRANT PROGRAM 15/11/2016
Why is IMCAS eligible?What is IMCAS?Since 1994, IMCAS has dedicated to providing top quality educational content for plastic surgeons, dermatologists and medical professionals in the medical aesthetics market. With five worldwide meetings and over 550 hours of learning per year, IMCAS has established itself as one of the most prestigious meetings in in the world of this specialty.
Why support IMCAS?In an area that is rapidly evolving, physicians need to keep their knowledge up to date with the latest developments, innovations and techniques. With hundreds of CME accredited hours of learning over the course of five worldwide congresses, IMCAS have been filling these educational needs of over 10,000 participants from over 170 countries globally and benefiting countless number of patients. While IMCAS is constantly striving to improve, your support will empower the mission to achieve the highest quality of teaching.
Where does the funding go?The grant received will be allocated directly to the educational content delivery and activities associated, with a core purpose to increase understanding of scientific and clinical issues. Gathering these tangible assets, IMCAS is able to bring intangible result that ultimately benefits the patients.Additionally, grantors can support specific topics or sessions within the meeting (for example anatomy or clinical dermatology sessions) or specific provisions or demographics within the meeting (for example funding registration fee waivers for young physicians/residents).In gratitude of the grantors’ generosity, an acknowledgment can be featured within the meeting program or signage, among others. IMCAS is committed to the principle of transparency; therefore the disclosure of the grant allocation is available upon request.
The next stepIn all cases, grantors are welcome to provide funds at any level without being tied to a minimal amount.You can provide a grant by making a request directly through the online platform. If you wish to receive more information on the granting process, please contact us at [email protected].
V6 GRANT PROGRAM 15/11/2016
98%of attendees plan to attend
IMCAS in the future
IMCAS KEY FIGURES*
10 000attendees
900key speakers
5meetings
550hours oflearning
7 500active
web accounts
60%returningattendees
(already attended IMCAS in the past)
52% EUROPE 6% NORTH AMERICA
15% MIDDLE EAST 5% ASIA
10% EASTERN EUROPE
5% LATIN AMERICA
6% AFRICA 1% OCEANIA
*per year - on imcas.comand academy.imcas.com
Geographical distribution and medical specialtiesof all IMCAS live and online attendees
FOCUS ONEUROPE
3,5%3,5%
3,5%4,5%
4,5%
4%
15%
SPAIN
FRANCE
UK
GERMANY
ITALY
GREECETURKEY
V6 GRANT PROGRAM 15/11/2016
SCIENTIF IC SOCIE TIES OF PL ASTIC SURGERY
SOMCEP Moroccan Society of Aesthetic Plastic Surgeons (in progress)
www.somcep.com
LSPRAS Lebanese Society of Plastic, Reconstructive and Aesthetic Surgerywww.lspras.com
SOFCEP French Society of Aesthetic Plastic Surgeons
www.sofcep.org
AICPE Italian Association of Plastic and Aesthetic Surgery
www.aicpe.org
BAAPS British Association of Aesthetic Plastic Surgeons
www.baaps.org.uk
SMCPRE Moroccan Society of Plastic, Reconstructive and Aesthetic Surgery
www.smcpre.com
TSPS Taiwan Society of Plastic Surgery
www.prsa.org.tw
ThSPRS Society of Plastic and Reconstructive Surgeons of Thailand(previous collaboration)
www.plasticsurgery.or.th
ThSAPS Society of Aesthetic Plastic Surgeons of Thailand(previous collaboration)
www.surgery.or.th
HSPAS Ho Chi Minh Society of Plastic and Aesthetic Surgery (Vietnam)
www.hoithammy.org
HKSPRAS Hong Kong Society of Plastic, Reconstructive and Aesthetic Surgeons(previous collaboration)www.plasticsurgery.org.hk
ISPAS Israel Society of Plastic and Aesthetic Surgery (in progress)
www.plasticsurgery.org.il
SCIENTIF IC SOCIE TIES OF FACI AL PL ASTIC SURGERY
TAFPRS Taiwan Academy of Facial Plastic and Reconstructive Surgery
www.tafprs.org.tw
SMRCPF Mexican Society of Rhinology and FacialPlastic Surgery
www.rinologiaycirugiaplasticafacial.org.mx
INTERNATIONAL ACADEMIC PARTNERSHIPS
V6 GRANT PROGRAM 15/11/2016
SCIENTIF IC SOCIE TIES OF AESTHE TIC SCIENCE
SCIENTIF IC SOCIE TIES OF DERM ATOLOGY
ESLD European Society for Laser and Energy Based Devices
www.esld.org
GLSFD Laser Group of the French Society of Dermatology (SFD)
www.groupelasersfd.com
ESAD Egyptian Society of Aesthetic Dermatology
SSDDS Saudi Society of Dermatology and Dermatologic Surgery
www.ssdds.org
TDA Taiwanese Dermatological Association
www.derma.org.tw
PERDOSKI Indonesian Society of Dermatology and Venereology
www.perdoski.org
JSAD Japanese Society of Aesthetic Dermatology
www.aesthet-derm.org
GCSFD Surgical Group of the French Society of Dermatology (SFD)(in progress)www.groupechirsfd.com
GLSTDV Laser Group of the Tunisian Society of Dermatology and Venereology (STDV)
www.groupelasersfd.com
EDS Emirates Dermatology Society
www.edsuae.com
SMD Moroccan Society of Dermatology(in progress)
www.smdermato.org
AMD Mexican Academy of Dermatology
www.amd.org.mx
IPS International Peeling Societywww.peelingsociety.com
GRIRG Genital Restoration Innovative Research Groupwww.grirg.org
JSAS Japanese Society of Aesthetic Surgerywww.jsas.or.jp
AAEGY Aesthetic Academy of Egyptwww.aaegy.org
THAICOSDERM Thai Society of CosmeticDermatology and Surgerywww.thaicosderm.org
CSI Cell Society (previous collaboration)www.cellsociety.org
ACCS Australasian College of Cosmetic Surgerywww.accs.org.au
ACG Aesthetic Consilium Groupwww.aestheticconsilium.com
INTERNATIONAL ACADEMIC PARTNERSHIPS
V6 GRANT PROGRAM 15/11/2016
PAST AND ONGOING ACCREDITATIONS
IMCAS ANNUAL WORLD CONGRESSPARISUEMS - European Union of Medical Specialists
ACCME - Accreditation Council for Continuing Medical Education
DPC - National Agency of Continuing Professional Development
IMCAS AMERICASIn Americas (America 2017) :
SMRCPF - Mexican Society of Rhinology and Facial Plastic Surgery
AMCPER - Mexican Association of Plastic, Reconstructive and Aesthetic Surgery
AMD - Mexican Academy of Dermatology
IMCAS ASIAIn Indonesia (Asia 2015) :
IDI - Indonesian Medical Association
In Taiwan (Asia 2016):
TSPS - Taiwan Society of Plastic Sugery
TDA - Taiwanese Dermatological Association
TAFPRS - Taiwan Academy of Facial Plastic and Reconstructive Surgery
IMCAS INDIAIn Goa (India 2015) :
MCI - Goa Medical Council
In Mumbai (India 2016) :
MCI - Maharashtra Medical Council
V6 GRANT PROGRAM 15/11/2016
2017 SEASON’S FUNDING OPPORTUNITIES:3 LIVE - 3 ONLINE*
*IMCAS Annual World Congress 2017
Activity Date: Friday 27 January 2017Activity Time: 10:30amActivity Duration: 1 hourActivity Venue: Palais des Congrès de ParisActivity Format: LIVE: chaired session with successive 6 to 20 min presentations with enduring material
Program Description:This session has been constructed in order to provide practitioners clear and precise data aimed at understanding the main challenges faced by doctors, and find the best solutions to improve patient outcome in the field of clinical dermatology in relation to psoriasis.
• Review and assess various biologic options for psoriasis • Evaluate the common therapy treatments and discuss the challenges physicians face when handling patients with the condition • Explore the development of the latest phototherapy technology and devices for targeting psoriasis
Target AudienceThe activity is designed to meet the needs of all healthcare professionals concerned, i.e. physicians, nurses, and professional staff members of medical practices who manage patients with psoriasis.
Accreditation1 AMA PRA Category 1 Credit(s)™ through (obtained through a joint providership with Advanced Knowledge in Healthcare - AKH Inc.)
Educational NeedsA substantial proportion of the US population has symptoms of psoriasis, which is 7.5 million1, 2.2% of the population. Patients with psoriasis are at elevated risk to develop other medical conditions. For example, the incidence of psoriasis patients getting Crohn’s disease and ulcerative colitis is 3.8 to 7.5 times greater than the general population.
Educational Objectives Upon completion of the educational activity, participants should be able to:
• Identify current trends in clinical dermatology • Discuss the current indications, limitations, and potential uses for photodynamic or superficial radiation therapy • Review how to effectively detect and diagnose the symptoms and determine the best treatment options • Assess current and emerging therapies for the condition • Examine innovations in drug delivery methods
Outcomes MeasurementsThe assessment plan will be provided upon eligibility criteria
TransparencyThe IMCAS Educational Grant process is in full accordance with the recommendations and the guidance of the Accreditation Council for Continuing Medical Education (ACCME), “National Physician Payment Transparency Program: OPEN PAYMENTS” commonly known as the “Sunshine Act,” and internal IMCAS Compliance policies.
Criteria for SuccessStatements of credit will be awarded based on the participant’s attendance and submission of the activity evaluation form.
REFERENCES • 1Menter A, Gottlieb A, Feldman SR, Van Voorhees AS et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol 2008 May;58(5):826-50.
Activity Title n° live 1/3: Clinical Dermatology – PsoriasisProgram Cost: Upon eligibility criteria
LIVE
V6 GRANT PROGRAM 15/11/2016
Activity Date: Friday 27 January 2017Activity Time: 1:30pmActivity Duration: 1 hourActivity Venue: Palais des Congrès de ParisActivity Format: LIVE: chaired session with successive 6 to 20 min presentations with enduring material
Program Description:This session has been constructed in order to provide practitioners clear and precise data aimed at understanding the main challenges faced by doctors, and find the best solutions to improve patient outcome in the field of clinical dermatology, particularly in the area of:
• Broad usage of biologics • Rosacea • Atopic dermatitis • Urticaria and itch
Target AudienceThe activity is designed to meet the needs of all healthcare professionals concerned, i.e. physicians, nurses, and professional staff members of medical practices specializing in clinical dermatology.
Accreditation1 AMA PRA Category 1 Credit(s)™ through (obtained through a joint providership with Advanced Knowledge in Healthcare - AKH Inc.)
Educational NeedsWe often take it for granted that our skin function normally, but for those who suffer from skin conditions, their life is very different. At any given time, one in three people in the United States suffers from dermatological conditions; let it be acne, eczema or vitiligo. Having skin condition does not only affect the patients’ physical health, but the emotional and psychological health as well, ultimately impacting the qualify of life.
Educational Objectives Upon completion of the educational activity, participants should be able to:
• Identify current trends in clinical dermatology • Discuss the current indications, limitations, and potential uses for photodynamic or superficial radiation therapy • Review how to effectively detect and diagnose the symptoms and determine the best treatment options • Assess current and emerging therapies for the condition • Examine innovations in drug delivery methods
Outcomes MeasurementsThe assessment plan will be provided upon eligibility criteria
TransparencyThe IMCAS Educational Grant process is in full accordance with the recommendations and the guidance of the Accreditation Council for Continuing Medical Education (ACCME), “National Physician Payment Transparency Program: OPEN PAYMENTS” commonly known as the “Sunshine Act,” and internal IMCAS Compliance policies.
Criteria for SuccessStatements of credit will be awarded based on the participant’s attendance and submission of the activity evaluation form.
Activity Title n° live 2/3: Clinical Dermatology – Innovations IIProgram Cost: Upon eligibility criteria
LIVE
V6 GRANT PROGRAM 15/11/2016
Activity Date: Friday 27 January 2017Activity Time: 4:00pmActivity Duration: 1 hourActivity Venue: Palais des Congrès de ParisActivity Format: LIVE: chaired session with successive 6 to 20 min presentations with enduring material
Program Description:This session has been constructed in order to provide practitioners clear and precise data aimed at understanding the main challenges faced by doctors, and find the best solutions to improve patient outcome in the field of clinical dermatology.
• Innovations in drug delivery – Receive the latest information for new prescribed and non-prescribed treatment modalities • What the future holds – Share strategies for staying ahead and maintaining a successful practice in this ever-changing industry • Innovations in the treatment of seborrheic keratosis – Explore new and emerging techniques and devices
Target AudienceThe activity is designed to meet the needs of all healthcare professionals concerned, i.e. physicians, nurses, and professional staff members of medical practices specializing in clinical dermatology.
Accreditation1 AMA PRA Category 1 Credit(s)™ through (obtained through a joint providership with Advanced Knowledge in Healthcare - AKH Inc.)
Educational NeedsAt the age of technology, our life is improving rapidly with all of the new concepts and gadgets available. And no doubt it also applies in the world of clinical dermatology as science and technology go hand in hand. Physicians have to stay on top in order to provide the most suitable and effective treatments to the patients.
Educational Objectives Upon completion of the educational activity, participants should be able to:
• Identify current trends in clinical dermatology • Discuss the current indications, limitations, and potential uses for photodynamic or superficial radiation therapy • Review how to effectively detect and diagnose the symptoms and determine the best treatment options • Assess current and emerging therapies for the condition • Examine innovations in drug delivery methods
Outcomes MeasurementsThe assessment plan will be provided upon eligibility criteria
TransparencyThe IMCAS Educational Grant process is in full accordance with the recommendations and the guidance of the Accreditation Council for Continuing Medical Education (ACCME), “National Physician Payment Transparency Program: OPEN PAYMENTS” commonly known as the “Sunshine Act,” and internal IMCAS Compliance policies.
Criteria for SuccessStatements of credit will be awarded based on the participant’s attendance and submission of the activity evaluation form.
Activity Title n° live 3/3: Clinical Dermatology –Innovations IIIProgram Cost: Upon eligibility criteria
LIVE
V6 GRANT PROGRAM 15/11/2016
Activity Date: March 1, 2017 onwardsActivity Expiry Date: March 1, 2018Activity Duration: 1 hourActivity Format: ONLINE: Recorded chaired session with successive 6 to 20 min presentations with enduring material
Program Description:This session has been constructed in order to provide practitioners clear and precise data aimed at understanding the main challenges faced by doctors, and find the best solutions to improve patient outcome in the field of clinical dermatology in relation to psoriasis.
• Review and assess various biologic options for psoriasis • Evaluate the common therapy treatments and discuss the challenges physicians face when handling patients with the condition • Explore the development of the latest phototherapy technology and devices for targeting psoriasis
Target AudienceThe activity is designed to meet the needs of all healthcare professionals concerned, i.e. physicians, nurses, and professional staff members of medical practices who manage patients with psoriasis.
Accreditation1 AMA PRA Category 1 Credit(s)™ through (obtained through a joint providership with Advanced Knowledge in Healthcare - AKH Inc.)
Educational NeedsA substantial proportion of the US population has symptoms of psoriasis, which is 7.5 million1, 2.2% of the population. Patients with psoriasis are at elevated risk to develop other medical conditions. For example, the incidence of psoriasis patients getting Crohn’s disease and ulcerative colitis is 3.8 to 7.5 times greater than the general population.
Educational Objectives Upon completion of the educational activity, participants should be able to:
• Identify current trends in clinical dermatology • Discuss the current indications, limitations, and potential uses for photodynamic or superficial radiation therapy • Review how to effectively detect and diagnose the symptoms and determine the best treatment options • Assess current and emerging therapies for the condition • Examine innovations in drug delivery methods
Outcomes MeasurementsThe assessment plan will be provided upon eligibility criteria
TransparencyThe IMCAS Educational Grant process is in full accordance with the recommendations and the guidance of the Accreditation Council for Continuing Medical Education (ACCME), “National Physician Payment Transparency Program: OPEN PAYMENTS” commonly known as the “Sunshine Act,” and internal IMCAS Compliance policies.
Criteria for SuccessStatements of credit will be awarded based on the participant’s attendance and submission of the activity evaluation form.
REFERENCES • 1Menter A, Gottlieb A, Feldman SR, Van Voorhees AS et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol 2008 May;58(5):826-50.
Activity Title n° online 1/3: Clinical Dermatology – PsoriasisProgram Cost: Upon eligibility criteria ONLINE
V6 GRANT PROGRAM 15/11/2016
Activity Date: March 1, 2017 onwardsActivity Expiry Date: March 1, 2018Activity Duration: 1 hourActivity Format: ONLINE: Recorded chaired session with successive 6 to 20 min presentations with enduring material
Program Description:This session has been constructed in order to provide practitioners clear and precise data aimed at understanding the main challenges faced by doctors, and find the best solutions to improve patient outcome in the field of clinical dermatology, particularly in the area of:
• Broad usage of biologics • Rosacea • Atopic dermatitis • Urticaria and itch
Target AudienceThe activity is designed to meet the needs of all healthcare professionals concerned, i.e. physicians, nurses, and professional staff members of medical practices specializing in clinical dermatology.
Accreditation1 AMA PRA Category 1 Credit(s)™ through (obtained through a joint providership with Advanced Knowledge in Healthcare - AKH Inc.)
Educational NeedsWe often take it for granted that our skin function normally, but for those who suffer from skin conditions, their life is very different. At any given time, one in three people in the United States suffers from dermatological conditions; let it be acne, eczema or vitiligo. Having skin condition does not only affect the patients’ physical health, but the emotional and psychological health as well, ultimately impacting the qualify of life.
Educational Objectives Upon completion of the educational activity, participants should be able to:
• Identify current trends in clinical dermatology • Discuss the current indications, limitations, and potential uses for photodynamic or superficial radiation therapy • Review how to effectively detect and diagnose the symptoms and determine the best treatment options • Assess current and emerging therapies for the condition • Examine innovations in drug delivery methods
Outcomes MeasurementsThe assessment plan will be provided upon eligibility criteria
TransparencyThe IMCAS Educational Grant process is in full accordance with the recommendations and the guidance of the Accreditation Council for Continuing Medical Education (ACCME), “National Physician Payment Transparency Program: OPEN PAYMENTS” commonly known as the “Sunshine Act,” and internal IMCAS Compliance policies.
Criteria for SuccessStatements of credit will be awarded based on the participant’s attendance and submission of the activity evaluation form.
Activity Title n° online 2/3: Clinical Dermatology – Innovations IIProgram Cost: Upon eligibility criteria ONLINE
V6 GRANT PROGRAM 15/11/2016
Activity Date: March 1, 2017 onwardsActivity Expiry Date: March 1, 2018Activity Duration: 1 hourActivity Format: ONLINE: Recorded chaired session with successive 6 to 20 min presentations with enduring material
Program Description:This session has been constructed in order to provide practitioners clear and precise data aimed at understanding the main challenges faced by doctors, and find the best solutions to improve patient outcome in the field of clinical dermatology.
• Innovations in drug delivery – Receive the latest information for new prescribed and non-prescribed treatment modalities • What the future holds – Share strategies for staying ahead and maintaining a successful practice in this ever-changing industry • Innovations in the treatment of seborrheic keratosis – Explore new and emerging techniques and devices
Target AudienceThe activity is designed to meet the needs of all healthcare professionals concerned, i.e. physicians, nurses, and professional staff members of medical practices specializing in clinical dermatology.
Accreditation1 AMA PRA Category 1 Credit(s)™ through (obtained through a joint providership with Advanced Knowledge in Healthcare - AKH Inc.)
Educational NeedsAt the age of technology, our life is improving rapidly with all the new concepts and gadgets available. And no doubt it also applies in the world of clinical dermatology as science and technology go hand in hand. Physicians have to stay on top in order to provide the most suitable and effective treatments to the patients.
Educational Objectives Upon completion of the educational activity, participants should be able to:
• Identify current trends in clinical dermatology • Discuss the current indications, limitations, and potential uses for photodynamic or superficial radiation therapy • Review how to effectively detect and diagnose the symptoms and determine the best treatment options • Assess current and emerging therapies for the condition • Examine innovations in drug delivery methods
Outcomes MeasurementsThe assessment plan will be provided upon eligibility criteria
TransparencyThe IMCAS Educational Grant process is in full accordance with the recommendations and the guidance of the Accreditation Council for Continuing Medical Education (ACCME), “National Physician Payment Transparency Program: OPEN PAYMENTS” commonly known as the “Sunshine Act,” and internal IMCAS Compliance policies.
Criteria for SuccessStatements of credit will be awarded based on the participant’s attendance and submission of the activity evaluation form.
Activity Title n° online 3/3: Clinical Dermatology –Innovations IIIProgram Cost: Upon eligibility criteria ONLINE
V6 GRANT PROGRAM 15/11/2016
